课题基金 / 基金详情

MRI & NEUROPSYCHOLOGICAL MARKERS FOR MANGANESE-INDUCED PARKINSONISM

MRI & NEUROPSYCHOLOGICAL MARKERS FOR MANGANESE-INDUCED PARKINSONISM
核磁共振成像
批准号：
7951300
负责人：
XUEMEI HUANG
金额：
$0.05万
依托单位：
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-04-01 至 2010-03-31
来源：
https://reporter.nih.gov/project-details/7951300
关键词：
Clinical ResearchComputer Retrieval of Information on Scientific Projects DatabaseDataExposure toFunctional Magnetic Resonance ImagingFundingFutureGrantInstitutionMagnetic Resonance ImagingManganeseMeasuresMetalsMethodologyNeurodegenerative DisordersNeuropsychological TestsParkinson DiseaseParkinsonian DisordersPilot ProjectsResearchResearch PersonnelResourcesRoleSourceUnited States National Institutes of Healthneuropsychological

项目摘要

项目成果

XUEMEI HUANG的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的目的是提供试点数据的影响，金属烟雾对神经心理学测试和功能磁共振成像的措施，可能提供一个合理的调查金属烟雾暴露的作用，如帕金森氏病神经退行性疾病。 这项试点研究的另一个目的是展示作为未来供资平台的方法。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to provide pilot data on the effects of metal fumes on neuropsychological tests and fMRI measures to potentially provide a rationale for investigating the role of metal fume exposure to neurodegenerative diseases such as Parkinson's disease. An additional purpose of this pilot study is to demonstrate the methodologies as a platform for future funding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance